Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Electromed, Inc. stock logo
ELMD
Electromed
$24.27
-1.7%
$23.91
$17.73
$35.56
$203.29M0.4780,249 shs21,973 shs
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$10.13
+0.7%
$10.02
$4.61
$11.04
$206.92M1.79186,047 shs129,733 shs
Nyxoah SA stock logo
NYXH
Nyxoah
$5.61
-1.1%
$5.65
$4.34
$11.87
$191.08M1.5378,944 shs22,506 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.34
+1.5%
$3.25
$3.03
$9.33
$54.91M1.3880,626 shs94,437 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Electromed, Inc. stock logo
ELMD
Electromed
0.00%-0.08%+4.43%+28.96%+5.94%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.00%+12.56%+0.50%+68.55%+49.08%
Nyxoah SA stock logo
NYXH
Nyxoah
0.00%-3.28%+24.94%-25.99%-41.50%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%+4.37%+6.71%-39.38%-47.32%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Electromed, Inc. stock logo
ELMD
Electromed
$24.27
-1.7%
$23.91
$17.73
$35.56
$203.29M0.4780,249 shs21,973 shs
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$10.13
+0.7%
$10.02
$4.61
$11.04
$206.92M1.79186,047 shs129,733 shs
Nyxoah SA stock logo
NYXH
Nyxoah
$5.61
-1.1%
$5.65
$4.34
$11.87
$191.08M1.5378,944 shs22,506 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.34
+1.5%
$3.25
$3.03
$9.33
$54.91M1.3880,626 shs94,437 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Electromed, Inc. stock logo
ELMD
Electromed
0.00%-0.08%+4.43%+28.96%+5.94%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.00%+12.56%+0.50%+68.55%+49.08%
Nyxoah SA stock logo
NYXH
Nyxoah
0.00%-3.28%+24.94%-25.99%-41.50%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%+4.37%+6.71%-39.38%-47.32%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Electromed, Inc. stock logo
ELMD
Electromed
3.50
Strong Buy$36.2549.36% Upside
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
3.40
Buy$13.5033.27% Upside
Nyxoah SA stock logo
NYXH
Nyxoah
2.50
Moderate Buy$15.00167.38% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.40
Hold$8.00139.52% Upside

Current Analyst Ratings Breakdown

Latest SRTS, ELMD, NYXH, and INFU Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/25/2025
Nyxoah SA stock logo
NYXH
Nyxoah
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/25/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
10/22/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
10/8/2025
Nyxoah SA stock logo
NYXH
Nyxoah
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
10/6/2025
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
9/27/2025
Nyxoah SA stock logo
NYXH
Nyxoah
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
9/25/2025
Electromed, Inc. stock logo
ELMD
Electromed
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
9/23/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHoldStrong Sell
9/22/2025
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$15.00
(Data available from 10/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Electromed, Inc. stock logo
ELMD
Electromed
$64M3.18$0.59 per share41.36$5.10 per share4.76
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$139.89M1.48$0.79 per share12.79$2.47 per share4.10
Nyxoah SA stock logo
NYXH
Nyxoah
$4.89M39.07N/AN/A$3.60 per share1.56
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.31$0.43 per share7.73$3.41 per share0.98
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Electromed, Inc. stock logo
ELMD
Electromed
$5.15M$0.8432.36N/A11.34%15.71%13.37%N/A
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$870K$0.23168.8632.68N/A1.12%2.78%1.41%N/A
Nyxoah SA stock logo
NYXH
Nyxoah
-$64.10M-$2.30N/AN/AN/A-1,541.84%-79.18%-54.92%11/5/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M-$0.06N/A14.52N/A-2.26%-1.58%-1.41%11/6/2025 (Confirmed)

Latest SRTS, ELMD, NYXH, and INFU Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/6/2025Q3 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.12N/AN/AN/A$6.31 millionN/A
11/5/2025Q3 2025
Nyxoah SA stock logo
NYXH
Nyxoah
-$0.60N/AN/AN/AN/AN/A
8/18/2025Q2 2025
Nyxoah SA stock logo
NYXH
Nyxoah
-$0.62-$0.63-$0.01-$0.63$1.33 million$1.58 million
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01-$0.06-$0.07-$0.06$9.30 million$7.32 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Electromed, Inc. stock logo
ELMD
Electromed
N/AN/AN/AN/AN/A
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
N/AN/AN/AN/AN/A
Nyxoah SA stock logo
NYXH
Nyxoah
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Electromed, Inc. stock logo
ELMD
Electromed
N/A
5.10
4.74
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.50
1.98
1.59
Nyxoah SA stock logo
NYXH
Nyxoah
0.29
2.63
2.38
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.14
5.79

Institutional Ownership

CompanyInstitutional Ownership
Electromed, Inc. stock logo
ELMD
Electromed
40.82%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
71.13%
Nyxoah SA stock logo
NYXH
Nyxoah
N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Electromed, Inc. stock logo
ELMD
Electromed
10.50%
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
11.40%
Nyxoah SA stock logo
NYXH
Nyxoah
17.11%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Electromed, Inc. stock logo
ELMD
Electromed
1608.38 million7.36 millionOptionable
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
41020.43 million19.10 millionOptionable
Nyxoah SA stock logo
NYXH
Nyxoah
11034.06 million28.23 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

Zacks Research Upgrades Sensus Healthcare (NASDAQ:SRTS) to Hold

New MarketBeat Followers Over Time

Media Sentiment Over Time

Electromed stock logo

Electromed NYSE:ELMD

$24.27 -0.42 (-1.70%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$24.24 -0.02 (-0.10%)
As of 10/24/2025 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

InfuSystem stock logo

InfuSystem NYSE:INFU

$10.13 +0.07 (+0.70%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$10.18 +0.05 (+0.49%)
As of 10/24/2025 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Nyxoah stock logo

Nyxoah NASDAQ:NYXH

$5.61 -0.06 (-1.06%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$5.58 -0.03 (-0.53%)
As of 10/24/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.34 +0.05 (+1.52%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$3.35 +0.01 (+0.30%)
As of 10/24/2025 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.